blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1309620

EP1309620 - COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISORDERS INVOLVING ANGIOGENESIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.08.2010
Database last updated on 23.04.2024
Most recent event   Tooltip27.08.2010Application deemed to be withdrawnpublished on 29.09.2010  [2010/39]
Applicant(s)For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2003/20]For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
Inventor(s)01 / BAKER, Kevin, P.
14006 Indian Run Drive
Darnestown, MD 20878 / US
02 / FERRARA, Napoleone
No 704, 2090 Pacific Avenue
San Francisco, CA 94109 / US
03 / GERBER, Hanspeter
No 5, 1121 Tennessee Street
San Francisco, CA 94107 / US
04 / GERRITSEN, Mary, E.
541 Parrott Drive
San Mateo, CA 94402 / US
05 / GODDARD, Audrey
110 Congo Street
San Francisco, CA 94131 / US
06 / GODOWSKI, Paul, J.
25 Orange Court
Hillsborough, CA 94010 / US
07 / GURNEY, Austin, L.
1 Debbie Lane
Belmont, CA 94002 / US
08 / HILLAN, Kenneth, J.
64 Seward Street
San Francisco, CA 94114 / US
09 / MARSTERS, Scot, A.
990 Cherry Street
San Carlos, CA 94070 / US
10 / PAN, James
2705 Coronet Boulevard
Belmont, CA 94002 / US
11 / PAONI, Nicholas, F.
1756 Terrace Drive
Belmont, CA 94002 / US
12 / STEPHAN, Jean-Philippe, F.
320 C Lansdale Avenue
Millbrae, CA 94030 / US
13 / WATANABE, Colin, K.
128 Corliss Drive
Moraga, CA 94556 / US
14 / WILLIAMS, P., Mickey
509 Alto Avenue
Half Moon Bay, CA 94019 / US
15 / WOOD, William, I.
35 Southdown Court
Hillsborough, CA 94010 / US
16 / YE, Weilan
119 Barkentine Street
Foster City, CA 94404 / US
 [2009/50]
Former [2003/20]01 / BAKER, Kevin, P.
14006 Indian Run Drive
Darnestown, MD 20878 / US
02 / FERRARA, Napoleone
No 704, 22090 Pacific Avenue
San Francisco, CA 94109 / US
03 / GERBER, Hanspeter
No 5, 1121 Tennessee Street
San Francisco, CA 94107 / US
04 / GERRITSEN, Mary, E.
541 Parrott Drive
San Mateo, CA 94402 / US
05 / GODDARD, Audrey
110 Congo Street
San Francisco, CA 94131 / US
06 / GODOWSKI, Paul, J.
2627 Easton Drive
Burlingame, CA 94010 / US
07 / GURNEY, Austin, L.
1 Debbie Lane
Belmont, CA 94002 / US
08 / HILLAN, Kenneth, J.
64 Seward Street
San Francisco, CA 94114 / US
09 / MARSTERS, Scot, A.
990 Cherry Street
San Carlos, CA 94070 / US
10 / PAN, James
2705 Coronet Boulevard
Belmont, CA 94002 / US
11 / PAONI, Nicholas, F.
1756 Terrace Drive
Belmont, CA 94002 / US
12 / STEPHAN, Jean-Philippe, F.
320 C Lansdale Avenue
Millbrae, CA 94030 / US
13 / WATANABE, Colin, K.
128 Corliss Drive
Moraga, CA 94556 / US
14 / WILLIAMS, P., Mickey
509 Alto Avenue
Half Moon Bay, CA 94019 / US
15 / WOOD, William, I.
35 Southdown Court
Hillsborough, CA 94010 / US
16 / YE, Weilan
119 Barkentine Street
Foster City, CA 94404 / US
Representative(s)Denison, Christopher Marcus
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
[N/P]
Former [2003/20]Denison, Christopher Marcus
Mewburn Ellis York House 23 Kingsway
London WC2B 6HP / GB
Application number, filing date01957073.820.06.2001
[2003/20]
WO2001US19692
Priority number, dateUS20000213637P23.06.2000         Original published format: US 213637 P
US20000219556P20.07.2000         Original published format: US 219556 P
US20000220624P25.07.2000         Original published format: US 220624 P
US20000220664P25.07.2000         Original published format: US 220664 P
WO2000US2071028.07.2000         Original published format: PCT/US00/20710
US20000222695P02.08.2000         Original published format: US 222695 P
US2000064365717.08.2000         Original published format: US 643657
WO2000US2352223.08.2000         Original published format: PCT/US00/23522
WO2000US2332824.08.2000         Original published format: PCT/US00/23328
US20000230978P07.09.2000         Original published format: US 230978 P
US2000066461018.09.2000         Original published format: US 664610
US2000066535018.09.2000         Original published format: US 665350
US20000242922P24.10.2000         Original published format: US 242922 P
US2000070923808.11.2000         Original published format: US 709238
WO2000US3095208.11.2000         Original published format: PCT/US00/30952
WO2000US3087310.11.2000         Original published format: PCT/US00/30873
WO2000US3267801.12.2000         Original published format: PCT/US00/32678
US2000074725920.12.2000         Original published format: US 747259
WO2000US3495620.12.2000         Original published format: PCT/US00/34956
US2001076760922.01.2001         Original published format: US 767609
US2001079649828.02.2001         Original published format: US 796498
WO2001US0652028.02.2001         Original published format: PCT/US01/06520
WO2001US0666601.03.2001         Original published format: PCT/US01/06666
US2001080270609.03.2001         Original published format: US 802706
US2001080868914.03.2001         Original published format: US 808689
US2001081674422.03.2001         Original published format: US 816744
US2001082836605.04.2001         Original published format: US 828366
US2001085420810.05.2001         Original published format: US 854208
US2001085428010.05.2001         Original published format: US 854280
US2001086602825.05.2001         Original published format: US 866028
US2001086603425.05.2001         Original published format: US 866034
WO2001US1709225.05.2001         Original published format: PCT/US01/17092
US2001087057430.05.2001         Original published format: US 870574
WO2001US1744330.05.2001         Original published format: PCT/US01/17443
WO2001US1780001.06.2001         Original published format: PCT/US01/17800
[2003/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0200690
Date:03.01.2002
Language:EN
[2002/01]
Type: A2 Application without search report 
No.:EP1309620
Date:14.05.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2002 takes the place of the publication of the European patent application.
[2003/20]
Search report(s)International search report - published on:EP13.03.2003
ClassificationIPC:C07K14/47, C12N15/12, A61K38/17, C07K16/18
[2003/20]
CPC:
C07K14/47 (EP); A61P27/02 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/20]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR DIAGNOSE UND DER BEHANDLUNG VON KRANKHEITEN, BEI DENEN DIE ANGIOGENESE EINE ROLLE SPIELT[2003/20]
English:COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DISORDERS INVOLVING ANGIOGENESIS[2003/20]
French:COMPOSITIONS ET PROCEDES DE DIAGNOSE ET TRAITEMENT DE MALADIES FAISANT INTERVENIR L'ANGIOGENESE[2003/20]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase02.01.2003National basic fee paid 
02.01.2003Designation fee(s) paid 
02.01.2003Examination fee paid 
Examination procedure20.12.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
02.01.2003Examination requested  [2003/20]
08.06.2005Despatch of a communication from the examining division (Time limit: M06)
24.01.2006Reply to a communication from the examining division
27.03.2006Despatch of a communication from the examining division (Time limit: M04)
04.08.2006Reply to a communication from the examining division
17.04.2007Despatch of a communication from the examining division (Time limit: M06)
29.08.2007Reply to a communication from the examining division
16.11.2009Communication of intention to grant the patent
27.03.2010Application deemed to be withdrawn, date of legal effect  [2010/39]
06.05.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2010/39]
Divisional application(s)EP08019420.2  / EP2042597
EP09004415.7  / EP2168980
EP09004417.3  / EP2077276
EP09004418.1  / EP2075253
EP10182597.4  / EP2275549
EP14166919.2  / EP2792747
Request for further processing for:24.01.2006Request for further processing filed
24.01.2006Full payment received (date of receipt of payment)
Request granted
09.02.2006Decision despatched
Fees paidRenewal fee
12.06.2003Renewal fee patent year 03
14.06.2004Renewal fee patent year 04
14.06.2005Renewal fee patent year 05
27.03.2006Renewal fee patent year 06
14.06.2007Renewal fee patent year 07
28.03.2008Renewal fee patent year 08
16.06.2009Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.06.201010   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0335243  (HARVARD COLLEGE [US]) [A] * the whole document *;
 [A]WO9529242  (CHILDRENS MEDICAL CENTER [US]) [A] * the whole document *;
 [X]WO9910363  (HUMAN GENOME SCIENCES INC [US], et al) [X] 1-19 * see secreted protein 24 *;
 [X]WO9933979  (CHIRON CORP [US]) [X] 1-19 * the whole document *;
 [X]WO9943802  (SAGAMI CHEM RES [JP], et al) [X] 1-19 * see clone HP02239. *;
 [XL]WO9946281  (GENENTECH INC [US], et al) [XL] 1-19 * see PRO181 *;
 [X]WO9950405  (GENETICS INST [US]) [X] 1-19 * see pk65_4 and seq.ID's 11 and 12 *;
 [XL]US5968744  (HILLMAN JENNIFER L [US], et al) [XL] 1-19 * the whole document *;
 [PXL]WO0053756  (GENENTECH INC [US], et al) [PXL] 1-19 * see seq.ID.322; L: priority. *;
 [PXL]WO0053751  (GENENTECH INC [US], et al) [PXL] 1-21,23,27-29,31,32,34,35 * the whole document *;
 [PX]WO0100828  (CORIXA CORP [US], et al) [PX] 1-21,23,27-29,31,32,34,35 * see seq.ID.327 *;
 [EL]WO0208284  (GENENTECH INC [US], et al) [EL] 1-35,37,41* See seq.ID's 1 and 120. L: priority. *;
 [A]  - FOLKMAN J, "CLINICAL APPLICATIONS OF RESEARCH ON ANGIOGENESIS", NEW ENGLAND JOURNAL OF MEDICINE, THE, MASSACHUSETTS MEDICAL SOCIETY, WALTHAM, MA, US, (19951228), vol. 333, no. 26, ISSN 0028-4793, pages 1757 - 1763, XP000654557 [A] * the whole document *

DOI:   http://dx.doi.org/10.1056/NEJM199512283332608
 [A]  - KLAGSBRUN M, "REGULATORS OF ANGIOGENESIS: STIMULATORS, INHIBITORS, AND EXTRACELLULAR MATRIX", JOURNAL OF CELLULAR BIOCHEMISTRY, LISS, NEW YORK, NY, US, (19911101), vol. 47, no. 3, ISSN 0730-2312, pages 199 - 200, XP000616588 [A] * the whole document *

DOI:   http://dx.doi.org/10.1002/jcb.240470302
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.